Matthew W. Strobeck - Director at Accelerate Diagnostics, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AXDX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew W. Strobeck since 20 May 2025

Holdings reported by Matthew W. Strobeck for Accelerate Diagnostics, Inc

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Employee Restricted Stock Units
Shares / value
236,842
Estimated value
$1,039,736
Report date
28 Jun 2023
Price
$4.39
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock
Shares / value
120,682
Estimated value
$529,794
Report date
23 Jan 2024
Price
$4.39
Ownership
By Birchview Fund, LLC
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock
Shares / value
2,000
Estimated value
$8,780
Report date
23 Jan 2024
Price
$4.39
Ownership
As UGMA Custodian for minor children
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock Warrants (right to buy)
Shares / value
100,000
Estimated value
Report date
23 Jan 2024
Price
Ownership
By Birchview Fund, LLC
Underlying class
Common Stock
Underlying amount

Transactions reported by Matthew W. Strobeck for Accelerate Diagnostics, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .